References
- Bauer RJ, Dedrick RL, White ML, Murray MJ, Garovoy MR. Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis. Journal of Pharmacokinetics and Biopharmacology 1999; 27: 397–420
- Bowen JD, Petersdorf SH, Richards TL, Maravilla KR, Dale DC, Price TH, St John TP, Yu AS. Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis. Clinical Pharmacology and Therapy 1998; 64: 339–346
- Jiang N, Chopp M, Chahwala S. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Research 1998; 788: 25–34
- Jiang N, Moyle M, Soule HR, Rote WE, Chopp M. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Annals of Neurology 1995; 38: 935–942
- Jonsson EFM, James I, Wild W, Larlsson M, Marshall S. Population pharmacokinetic/pharmacodynamic (PK/PD) of UK-279,276 (NIF) in healthy male volunteers and patients. Clinical Pharmacology and Therapeutics 2001; 69: P54
- Mahmood I, Balian JD. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Clinical Pharmacokinetics 1999; 36: 1–11
- Moyle M, Foster DL, McGrath DE, Brown SM, Laroche Y, De Meutter J, Stanssens P, Bogowitz CA, Fried VA, Ely JA, Soule HR, Vlasuk GP. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. Journal of Biology and Chemistry 1994; 269: 10008–10015
- Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): A nonplasmin fibrinolytic pathway. Blood 1993; 82: 2414–2422
- Walzog B, Gaehtgens P. Adhesion molecules: The path to a new understanding of acute inflammation. News in the Physiology Sciences 2000; 15: 107–113
- Webster R. Neutrophil inhibitor factor (rNIF): A case study in pharmacokinetics and metabolism. Drug Metabolism Reviews 2000; 32: 21
- Webster R, Phipps J, Hyland R, Walker D. Evaluation of the role of the asialoglycoprotein receptor in the clearance of UK-279,276 (recombinant neutrophil inhibitory factor). Xenobiotica 2003; 33: 945–956
- Webster R, Taberner J, Edgington A, Guhan S, Varghese J, Feeney H, Blocker L, Jezequel SG. Role of sialylation in determining the pharmacokinetics of neutrophil inhibitory factor (NIF) in the Fischer 344 rat. Xenobiotica 1999; 29: 1141–1155